Abstract
This study aimed to prospectively evaluate the effectiveness, patient satisfaction,
and early adverse events of using the hyaluronic acid filler VYC-20L for the treatment
of infraorbital hollowing. A total of 21 participants underwent injection of VYC-20L.
FACE-Q satisfaction surveys before and after treatment along with early adverse events
surveys were conducted. Pre- and posttreatment photos were graded, and the Allergan
Infraorbital Hollows Scale was used to assess the difference in infraorbital hollowing.
The results showed infraorbital hollowing improvement with VYC-20L was significant
(p < 0.001). FACE-Q Satisfaction with Eyes scores on average were 27 points higher after
treatment (p < 0.001). The mean FACE-Q Satisfaction with Decision score was 74.1%. The most common
short-term adverse symptoms were tenderness (67%), swelling (62%), and bruising (52%).
This study concludes that VYC-20L is an effective nonsurgical treatment option for
infraorbital hollowing with high patient satisfaction.
Keywords
infraorbital hollows - hyaluronic acid - filler - VYC-20L
